Bysani Chandrasekar

7PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsMetabolic medicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 13, 2025
Female Cardioprotection in a Mouse Model of Alcohol-Associated Cardiomyopathy.

Joshua M Edavettal, Meagan Donovan, Nicholas R Harris

|Aug 18, 2025
Cardiomyocyte-specific LARP6 overexpression prevents angiotensin II-induced myocardial dysfunction and interstitial fibrosis.

Jacob J Russell, Tadashi Yoshida, Lixin Ma

|Aug 04, 2025
Loss of hepatocyte-specific RECK exacerbates metabolic dysfunction-associated steatohepatitis.

Ryan J Dashek, Taylor J Kelty, Rory P Cunningham

|Oct 13, 2023
Empagliflozin Reverses Oxidized LDL-Induced RECK Suppression, Cardiotrophin-1 Expression, MMP Activation, and Human Aortic Smooth Muscle Cell Proliferation and Migration.

Bysani Chandrasekar, Srinivas Mummidi, Vincent G DeMarco

|Dec 02, 2021
Macrophage-Specific IGF-1 Overexpression Reduces CXCL12 Chemokine Levels and Suppresses Atherosclerotic Burden in Apoe-Deficient Mice.

Patricia Snarski, Sergiy Sukhanov, Tadashi Yoshida

|Nov 03, 2021
Quantification of myocardial fibrosis using noninvasive T2-mapping magnetic resonance imaging: Preclinical models of aging and pressure overload.

Li E Lee, Bysani Chandrasekar, Ping Yu

Pageof 2

Frequent Collaborators

2 joint publications

Lixin Ma

2 joint publications

Tadashi Yoshida

1 joint publications

Li E Lee

1 joint publications

Ping Yu